Cargando…
In vivo Protein Interference: Oral Administration of Recombinant Yeast-Mediated Partial Leptin Reduction for Obesity Control
Obesity-related diseases are always the major health problems that concern the whole world. Serial studies have reported that obesity development is closely related to the out-of-control leptin encoded by the obesity gene (ob). The latest report declaimed “Less Is More,” a model explaining that part...
Autores principales: | Yue, Feng, Du, Lihong, Wang, Ruyu, Han, Baoquan, Zhang, Xiaojun, Yao, Zhangzhang, Zhang, Wenqiang, Cai, Chang, Zhang, Zhiying, Xu, Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237534/ https://www.ncbi.nlm.nih.gov/pubmed/35774455 http://dx.doi.org/10.3389/fmicb.2022.923656 |
Ejemplares similares
-
Prokaryotic Argonaute Protein from Natronobacterium gregoryi Requires RNAs To Activate for DNA Interference In Vivo
por: Xing, Jiani, et al.
Publicado: (2022) -
In ovo administration of human recombinant leptin shows dose dependent angiogenic effect on chicken chorioallantoic membrane
por: Manjunathan, Reji, et al.
Publicado: (2015) -
Recombinant hemagglutinin displaying on yeast reshapes congenital lymphocyte subsets to prompt optimized systemic immune protection against avian influenza infection
por: Zhang, Han, et al.
Publicado: (2023) -
Partial leptin deficiency confers resistance to diet-induced obesity in mice
por: Zhao, Shangang, et al.
Publicado: (2020) -
In vitro and in vivo recombination of heterologous modules for improving biosynthesis of astaxanthin in yeast
por: Qi, Dan-Dan, et al.
Publicado: (2020)